ArticleGenes & diseases2025

Systematic pan-cancer analysis identifies DNASE2 as a potential prognostic marker and immunotherapeutic target for glioblastoma multiforme.

Jun Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.